XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   226,505      
Beginning balance at Dec. 31, 2022 $ 562,904 $ 227 $ 2,099,782 $ (4,765) $ (1,532,340)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (157,848)       (157,848)
Other comprehensive income (loss) 2,079     2,079  
Issuance of common stock in conjunction with equity plans (in shares)   3,843      
Issuance of common stock in conjunction with equity plans 9,821 $ 3 9,818    
Share-based compensation expense 35,843   35,843    
Ending balance (in shares) at Jun. 30, 2023   250,473      
Ending balance at Jun. 30, 2023 641,999 $ 250 2,334,623 (2,686) (1,690,188)
Beginning balance (in shares) at Mar. 31, 2023   249,803      
Beginning balance at Mar. 31, 2023 692,117 $ 250 2,314,146 (1,924) (1,620,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (69,833)       (69,833)
Other comprehensive income (loss) (762)     (762)  
Issuance of common stock in conjunction with equity plans (in shares)   670      
Issuance of common stock in conjunction with equity plans 2,586 $ 0 2,586    
Share-based compensation expense 17,891   17,891    
Ending balance (in shares) at Jun. 30, 2023   250,473      
Ending balance at Jun. 30, 2023 $ 641,999 $ 250 2,334,623 (2,686) (1,690,188)
Beginning balance (in shares) at Dec. 31, 2023 267,744 267,744      
Beginning balance at Dec. 31, 2023 $ 701,304 $ 268 2,539,892 219 (1,839,075)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (251,497)       (251,497)
Other comprehensive income (loss) (742)     (742)  
Issuance of common stock from Underwritten Public Equity Offering, net of issuance costs (in shares)   20,125      
Issuance of common stock from Underwritten Public Equity Offering, net of issuance costs 189,200 $ 20 189,180    
Issuance of common stock in conjunction with equity plans (in shares)   4,747      
Issuance of common stock in conjunction with equity plans 6,891 $ 4 6,887    
Share-based compensation expense $ 36,744   36,744    
Ending balance (in shares) at Jun. 30, 2024 272,491 272,491      
Ending balance at Jun. 30, 2024 $ 492,700 $ 272 2,583,523 (523) (2,090,572)
Beginning balance (in shares) at Mar. 31, 2024   272,280      
Beginning balance at Mar. 31, 2024 649,017 $ 272 2,566,304 (306) (1,917,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (173,319)       (173,319)
Other comprehensive income (loss) (217)     (217)  
Issuance of common stock in conjunction with equity plans (in shares)   211      
Issuance of common stock in conjunction with equity plans 0 $ 0      
Share-based compensation expense $ 17,219   17,219    
Ending balance (in shares) at Jun. 30, 2024 272,491 272,491      
Ending balance at Jun. 30, 2024 $ 492,700 $ 272 $ 2,583,523 $ (523) $ (2,090,572)